Sanofi continued to suffer from generic competition as sales declined 5.3% to €8.1 billion in the first quarter and operating income plunged by 33.5% to €1.5 billion. Business net income, a non-GAAP financial measure, fell by 33.5% to €1.61 billion.
Sanofi continued to suffer from generic competition as sales declined 5.3% to €8.1 billion in the first quarter and operating income plunged by 33.5% to €1.5 billion. Business net income, a non-GAAP financial measure, fell by 33.5% to €1.61 billion.